Abstract
Meta-analysis of real-world adherence and persistence of maintenance once- or twice-daily oral disease-modifying drugs (dimethyl fumarate, fingolimod, and teriflunomide) in multiple sclerosis (P3.2-041)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have